Therapeutic advances in multiple sclerosis
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that
causes significant disability and healthcare burden. The treatment of MS has evolved over …
causes significant disability and healthcare burden. The treatment of MS has evolved over …
Early use of high-efficacy therapies in multiple sclerosis in the United States: benefits, barriers, and strategies for encouraging adoption
BA Singer, J Feng, H Chiong-Rivero - Journal of Neurology, 2024 - Springer
Multiple sclerosis (MS) is characterized by progressive neuroinflammation and
neurodegeneration from disease onset that, if left untreated, can result in the accumulation …
neurodegeneration from disease onset that, if left untreated, can result in the accumulation …
In vivo degradation forms, anti-degradation strategies, and clinical applications of therapeutic peptides in non-infectious chronic diseases
Y Tasdemiroglu, RG Gourdie, JQ He - European journal of pharmacology, 2022 - Elsevier
Current medicinal treatments for diseases comprise largely of two categories: small
molecular (chemical)(eg, aspirin) and larger molecular (peptides/proteins, eg, insulin) drugs …
molecular (chemical)(eg, aspirin) and larger molecular (peptides/proteins, eg, insulin) drugs …
Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches
Background Multiple sclerosis (MS) is a central nervous system (CNS) demyelinating
autoimmune disease with increasing global prevalence. It predominantly affects females …
autoimmune disease with increasing global prevalence. It predominantly affects females …